Mylan NV (NASDAQ:MYL)

41.21
Delayed Data
As of Feb 21
 -0.13 / -0.31%
Today’s Change
29.39
Today|||52-Week Range
47.82
-2.60%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Abbott Laboratories
Sale3/23/201744,000,000$41.60$1.8B-0.95%
Bresch Heather M
Chief Executive Officer
Sale1/08/201844,067$45.00$2.0M-7.52%
Bresch Heather M
Chief Executive Officer
Sale1/09/201830,933$45.00$1.4M-6.95%
Malik Rajiv
President
Sale6/09/201725,000$40.00$1.0M+2.79%
Mauro Anthony
Chief Commercial Officer
Sale6/09/201710,000$40.00$400.0K+2.79%
Bresch Heather M
Chief Executive Officer
Sale3/04/20172,745$45.18$124.0K-6.43%
Malik Rajiv
President
Sale3/04/20171,682$45.18$76.0K-6.43%
Campbell Paul
Corporate Officer
Sale6/16/20171,917$36.72$70.4K+12.23%
Campbell Paul
Corporate Officer
Sale6/16/20176,294$11.18$70.4K+12.23%
Leech Douglas J
Director
Sale6/22/20171,529$39.01$59.6K+5.64%
Page of 3